Reference
- Connors, J.M. and O'Reilly, S.E. (1997) "Treatment considerations in the elderly patient with lymphoma", HematoL OncoL Clin. North. Am., 11, 949–960.
- Devesa, S.S. and Fears, T. (1992) "Non-Hodgkin's lymphoma time trends: United States and International data", Cancer Res., 52\(Suppl 19), 5432— 5440s.
- Weisenburger, D.D. (1994) "Epidemiology of non-Hodgkin's lymphoma: recent findings regarding an emerging epidemic", Ann. OncoL, 5\(Suppl 1), 19 — 24s.
- Errante, D., Sorio, R., Zagonel, V., Carbone, A., Monfardini, S. and Tirelli, U. (1991) "A Phase II study of oralidarubicin in previously untreated elderly patients with non-Hodgkin lympho-ma", Am. J. Clin. OncoL, 14, 243–245.
- Fisher, RI., Gaynor, E.R., Dahlberg, S., Oken, M.M., Grogan, T.M., Mize, E.M., etal. (1993) "Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma", N. Engl. J. Med., 328, 1002 — 1006.
- Coiffier, B., Lepage, E., Briere, J., Herbrecht, R., Tilly, H., Bouabdallah, R., etal. (2002) "CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large B-cell lymphoma", N. EngL J. Med., 346, 235–242.
- Philip, T., Guglielmi, C., Hagenbeek, A., Somers, R., Van der Leilie, H., Bron, D., et al. (1995) "Autologous bone marrow transplanta-tion as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma", N. Engl. J. Med., 333, 1540— 1545.
- Harris, N.L., Jaffe, ES., Stein, H., Banks, P.M., Chan, J.K., Cleary, M.L., et al. (1994) "A revised European-American classification of lymphoid neoplasms: a proposal from the international lymphoma study group", Blood, 84, 1361–1392.
- Sonnen, R., Schmidt, W.-P., Kuse, R. and Shmitz, N. (2002) "Treatment results of aggressive B non-Hodgkin's lymphoma in advanced age considering comorbidity", Br. J. HaematoL, 119, 634— 639.
- Villela, L., Lopez-Guillermo, A., Montoto, S., Rives, S., Bosch, F., Perales, M., et al. (2001) "Prognostic features and outcome in patients with diffuse large B-cell lymphoma who do not achieve a complete remission to first-line regimens", Cancer, 91, 1557 —1562.